Veracyte Announces Pivotal Clinical Validation Data for Afirma Genomic Sequencing Classifier Presented at World Congress on Thyroid Cancer

Stock Information for Veracyte Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Veracyte Inc.

Veracyte Announces Third Quarter 2018 Financial Results
Veracyte to Host Conference Call and Webcast to Discuss Third Quarter 2018 Financial Results on Monday, October 29, 2018
Veracyte Announces Presentation of "Real World" Clinical Utility Data at CHEST 2018 Showing Percepta Classifier Reduces Invasive Procedures in Lung Cancer Diagnosis
Veracyte Announces Presentation of Data Confirming Envisia Genomic Classifier's Ability to Improve Diagnosis of Idiopathic Pulmonary Fibrosis
Veracyte Announces that New Data from Multiple Studies Demonstrate "Real World" Performance of Afirma GSC and Xpression Atlas in Thyroid Cancer Diagnosis
Veracyte to Present at the Cantor Fitzgerald Global Healthcare Conference
Veracyte Announces New Data Reinforcing Clinical Value of Genomic Tests In Lung Disease Diagnoses to Be Presented at CHEST Annual Meeting 2018
Veracyte Announces Multiple Studies to Be Presented at ATA Annual Meeting Demonstrating "Real World" Performance of Afirma GSC and Xpression Atlas in Thyroid Cancer Diagnosis

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.